| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 04/08/2008 | US7354943 Statine derivatives for the treatment of Alzheimer's disease |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008039587A1 Authenticatable polymer articles comprising benzoxazole and benzothiazole authentication compounds |
| 04/03/2008 | WO2008038955A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 04/03/2008 | WO2008017827A3 Azole and thiazole derivatives and their uses |
| 04/03/2008 | WO2008017816A3 Chemical compounds |
| 04/03/2008 | WO2008016883A3 Inhibitors of plasma kallikrein |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2007130429A3 Histone deacetylase and tubulin deacetylase inhibitors |
| 04/03/2008 | WO2007017728A3 Novel heterocyclic compounds |
| 04/03/2008 | US20080081913 Benzoxazole and benzothiazole compounds and methods therefor |
| 04/03/2008 | US20080081906 cefdinir intermediate |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/02/2008 | EP1904467A1 Urea glucokinase activators |
| 04/02/2008 | EP1904466A1 Dicycloalkyl urea glucokinase activators |
| 04/02/2008 | EP1904439A2 Sphingosine kinase inhibitors |
| 04/02/2008 | EP1638556B1 2-aminobenzothiazoles as cb1 receptor inverse agonists |
| 04/02/2008 | EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides |
| 04/02/2008 | CN101155792A Amidopropoxyphenyl orexin receptor antagonists |
| 04/02/2008 | CN101155791A Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
| 04/02/2008 | CN101153028A Compounds with antimicrobial antiviral activity |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 04/01/2008 | US7351732 Serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists; neuroprotective agents; cerebral damage due to traumatic or ischemic stroke; 2-[4-[(Chroman-2-yl)methylamine]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazol |
| 04/01/2008 | US7351727 Inhibitors of 15-lipoxygenase |
| 04/01/2008 | US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
| 04/01/2008 | US7351401 Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 04/01/2008 | CA2332713C Hydroxamic acid derivatives as antibacterials |
| 03/27/2008 | WO2008036642A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | WO2008008660A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/27/2008 | WO2007127212A3 Anti-viral agents that activate rnase l |
| 03/27/2008 | US20080076920 Preparation of thiazoles |
| 03/27/2008 | US20080076914 Method of Deprotection |
| 03/27/2008 | US20080076809 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss composition comprising it and its uses |
| 03/27/2008 | US20080076735 Cytoskeletal active compounds, composition and use |
| 03/27/2008 | US20080075692 prophylaxis of blood disorder such as sickle cell anemia, beta -thalassemia, neutropenia or thrombocytopenia, comprising administering carboxylic acids, that stimulates production of fetal hemoglobin, hematopoiesis, erythropoiesis, myelopoiesis and neutrophil production |
| 03/27/2008 | CA2663057A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/26/2008 | EP1903042A2 An improved process for hydrogenation of 5-(substituted Benzylidene) 2,4- Thiazolidine Dione compounds to give corresponding ( +/- ) 5- (substituted Benzyl ) 2,4-Thiazolidine Dione |
| 03/26/2008 | EP1903030A1 Method for catalytic manufacture of aromatic or heteroaromatic nitriles |
| 03/26/2008 | EP1902022A1 Piperazine heteroaryl derivates as gpr38 agonists |
| 03/26/2008 | EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/26/2008 | EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 03/26/2008 | CN100376551C Semicarbazone synthesis method |
| 03/25/2008 | USRE40183 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348348 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers |
| 03/25/2008 | US7348347 Serotonin reuptake inhibitors; for depression and pain; 2-cyclohexyl-N-{4-[4-(2-dimethylaminoethyl)piperazin-1-carbonyl]-4,5,6,7-tetrahydrobenzthiazol-2-yl)-acetamide |
| 03/25/2008 | US7348346 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/20/2008 | WO2008033932A2 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors |
| 03/20/2008 | WO2008033455A2 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
| 03/20/2008 | WO2008032631A1 Aromatic amine derivative and organic electroluminescent device using the same |
| 03/20/2008 | WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 03/20/2008 | WO2008019090A3 Agonists of the sphingosine-1-phosphate receptor |
| 03/20/2008 | WO2008016692A3 Chemical compounds |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | WO2007084391A3 Thiazole compounds as protein kinase b ( pkb) inhibitors |
| 03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
| 03/20/2008 | US20080070946 Hydroxymethylbenzothiazoles Amides |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070910 aromatic or heterocyclic/heterobicyclic carbamate compounds as protease inhibitors , useful for inhibiting the development of drug resistance of HIV in HIV infected animals; improved pharmacokinetics; protease inhibitors |
| 03/20/2008 | US20080070905 An enzyme in the tryptophan degradation pathway, used to treat neurodegenerative disorders, certain cancers, drug addiction; 2-sulfonamido-substituted oxazole, imidazole or thiazole compounds such as 3,4-dimethoxy-N-[4-(3-nitrophenyl)-5-dimethylaminomethyl-1,3-thiazole-2-yl]benzenesulfonamide |
| 03/20/2008 | US20080070866 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/19/2008 | EP1899309A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 03/19/2008 | EP1898940A1 Inhibitors of the alpha2beta 1/gpia-iia integrin |
| 03/19/2008 | EP1898908A2 Novel chemical compounds and the uses thereof as a medicament |
| 03/19/2008 | EP1636223B1 Benzothiazole derivatives as adenosine receptor ligands |
| 03/19/2008 | EP1466910B1 Process for producing 2-cyanoimino-1,3-thiazolidine |
| 03/19/2008 | EP1283711B1 Peptide deformylase inhibitors |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | CN101146805A Production method for thiazolidinedione compound and its production intermediate |
| 03/19/2008 | CN101146784A Thiazole derivatives as PPARª delta ligands and their manufacturing process |
| 03/19/2008 | CN101146783A Organoselenium containing compounds and their use |
| 03/19/2008 | CN101146782A Metasubstituted thiazolidinones, their manufacture and use as a drug |
| 03/19/2008 | CN101146777A Carboxanilides as microbiocides |
| 03/19/2008 | CN101143856A Method of producing rubber vulcanization accelerator DZ |
| 03/19/2008 | CN101143217A Treatment of neurological and neuropsychological disorders |
| 03/18/2008 | US7345180 Compound inhibiting dipeptidyl peptidase IV |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345067 peroxisome proliferator activators such as (2-methyl-4-{methyl-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethyl]-amino}-phenoxy)-acetic acid, used as lipid modulators and insulin sensitizers |
| 03/18/2008 | US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 03/18/2008 | US7345060 E.g., biphenyl-2-ylcarbamic acid 1-{9-[2-(4-hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)ethylamino]nonyl}piperidin-4-yl ester;respiratory system disorders; bronchodilators; chronic obstructive pulmonary disease or asthma; affinity for dopamine D2 receptors; used with phosphodiesterase-4 inhibitor |
| 03/18/2008 | US7345043 Inhibitors of histone deacetylase |
| 03/18/2008 | CA2429378C Improved process for water soluble azole compounds |
| 03/18/2008 | CA2326441C Process for purification of a cephalosporin derivative |
| 03/18/2008 | CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2008030266A2 Insecticidal n-substituted (heteroaryl)alkyl sulfilmines |
| 03/13/2008 | WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 03/13/2008 | WO2008008718A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/13/2008 | WO2007107311A3 Organic sulphinic acid derivatives |
| 03/13/2008 | WO2007095603A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 03/13/2008 | US20080064874 2-Halofuryl/Thienyl-3-Carboxamides |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064699 Novel compounds as cannabinoid receptor ligands and uses thereof |